Leidos Awarded $143M DIA Technology Platform Contract

News provided by

Feb 15, 2024, 08:00 ET

RESTON, Va., Feb. 15, 2024 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE® 500 science and technology global leader, was recently awarded a new task order contract from the Defense Intelligence Agency's (DIA) Science & Technology (S&T) Directorate. Through this award, Leidos will design and implement a Tasking, Collection, Processing, Exploitation and Dissemination (TCPED) system for the DIA's Open Source Intelligence Integration Center (OSIC).

The task order award has a total estimated value of $143 million under the DOMEX Technology Platform (DTP) single award, indefinite delivery, indefinite quantity contract (IDIQ). Work will be performed in the National Capital Region with remote software development across Leidos facilities.

The new task order builds upon the agency's ongoing success with the National Media Exploitation Center's (NMEC) Data Discovery Platform (D3P) under the DTP IDIQ. D3P enhances the processing and enrichment of petabytes of unstructured, heterogeneous multi-modal data from across the Department of Defense, intelligence community and partners. This enables discovery, retrieval and sharing of vital intelligence data across multiple federal agencies.

"This award serves as an important investment to operationalize artificial intelligence/machine learning capabilities in support of a critical intelligence mission," said Roy Stevens, Leidos National Security Sector President. "Our work is a testament to the Leidos legacy of innovative, mission-focused and data-driven solutions. We look forward to extending our technical and mission success at NMEC to OSIC and across the DIA S&T Directorate."

The new program will bring together Leidos data science research and technology development teams from NMEC to expand collection and exploitation work at OSIC. This work will help OSIC address future national security challenges by operationalizing artificial intelligence and machine learning, enabling new insights from the nation's most critical and sensitive data streams.

Certain statements in this announcement constitute "forward-looking statements" within the meaning of the rules and regulations of the U.S. Securities and Exchange Commission (SEC). These statements are based on management's current beliefs and expectations and are subject to significant risks and uncertainties. These statements are not guarantees of future results or occurrences. A number of factors could cause our actual results, performance, achievements, or industry results to be different from the results, performance, or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, the "Risk Factors" set forth in Leidos' Annual Report on Form 10-K for the fiscal year ended December 30, 2022, and other such filings that Leidos makes with the SEC from time to time. Readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. Leidos does not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statements were made.

About Leidos

Leidos is a Fortune 500® innovation company rapidly addressing the world's most vexing challenges in national security and health. The company's global workforce of 47,000 collaborates to create smarter technology solutions for customers in heavily regulated industries. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $15.4 billion for the fiscal year ended December 29, 2023. For more information, visit www.leidos.com.

Media Contacts:
Melissa Dueñas
(571) 526-6850
[email protected]

Alyssa Pettus
(571) 526-6743
[email protected]

Greg Hellman
(571) 526-7592
[email protected]

SOURCE Leidos